Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 1.76% is in line with its 3-year average of 1.75%, around the middle of its 3-year range (0.00%–3.34%).
44.57% below its 12-month average of 3.17%.
Annual fiscal-year return on assets; no daily interpolation.
RETURN ON ASSETS (ROA)
1.76%
RETURN ON ASSETS (ROA) AVG TTM
3.17%
RETURN ON ASSETS (ROA) AVG 3Y
1.75%
RETURN ON ASSETS (ROA) AVG 5Y
N/A
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-44.57%
CURRENT VS 3Y AVG
+0.57%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
5.14%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-65.76%
vs the sector median at left
Market Cap
$29.85B
Return on Assets (ROA)
4.27%
TTM Avg
5.83%
3Y Avg
5.87%
5Y Avg
14.86%
Market Cap
$30.21B
Return on Assets (ROA)
0.67%
TTM Avg
13.34%
3Y Avg
15.53%
5Y Avg
17.15%
Market Cap
$30.66B
Return on Assets (ROA)
-6.14%
TTM Avg
-2.29%
3Y Avg
0.04%
5Y Avg
0.75%
Market Cap
$30.88B
Return on Assets (ROA)
17.35%
TTM Avg
17.37%
3Y Avg
16.33%
5Y Avg
15.33%
Market Cap
$31.32B
Return on Assets (ROA)
2.60%
TTM Avg
5.11%
3Y Avg
6.74%
5Y Avg
8.29%
Market Cap
$31.59B
Return on Assets (ROA)
15.49%
TTM Avg
11.04%
3Y Avg
9.26%
5Y Avg
8.83%
Market Cap
$31.77B
Return on Assets (ROA)
16.99%
TTM Avg
17.06%
3Y Avg
15.57%
5Y Avg
14.60%
Market Cap
$26.40B
Return on Assets (ROA)
5.41%
TTM Avg
4.41%
3Y Avg
4.42%
5Y Avg
6.18%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Medline Inc. (MDLN) | $29.23B | 1.76% | 3.17% | 1.75% | N/A |
| GE HealthCare Technologies Inc. (GEHC)vs › | $29.85B | 4.27% | 5.83% | 5.87% | 14.86% |
| Waters Corporation (WAT)vs › | $30.21B | 0.67% | 13.34% | 15.53% | 17.15% |
| Centene Corp. (CNC)vs › | $30.66B | -6.14% | -2.29% | 0.04% | 0.75% |
| Zoetis Inc. (ZTS)vs › | $30.88B | 17.35% | 17.37% | 16.33% | 15.33% |
| Biogen Inc. (BIIB)vs › | $31.32B | 2.60% | 5.11% | 6.74% | 8.29% |
| DexCom, Inc. (DXCM)vs › | $31.59B | 15.49% | 11.04% | 9.26% | 8.83% |
| ResMed Inc. (RMD)vs › | $31.77B | 16.99% | 17.06% | 15.57% | 14.60% |
| Labcorp Holdings Inc. (LH)vs › | $26.40B | 5.41% | 4.41% | 4.42% | 6.18% |
| Mettler-Toledo International Inc. (MTD)vs › | $26.25B | 24.67% | 25.02% | 24.63% | 23.85% |
ROA
1.8%
ROE
6.0%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 3.01% |
| 2024-12-31 | 3.34% |
| 2023-12-31 | 0.65% |
| 2022-12-31 | 0.00% |
